Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.
Nasdaq Down 0.5%; Clearfield Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday’s Mid-Day Session
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 26.7% to $21.84 during Friday’s regular session. As of 12:30 EST,…
Dow Surges Over 100 Points; Foot Locker Earnings Top Views
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.
IVERIC bio Secures Breakthrough Therapy Tag For Its Flagship Geographic Atrophy Candidate
The FDA has granted Breakthrough Therapy designation to IVERIC bio Inc’s (NASDAQ:ISEE) avacincaptad pegol (ACP, also known as Zimura), a novel investigational…
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Analyst Ratings for IVERIC bio
IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter:
Jefferies Downgrades IVERIC bio to Hold, Lowers Price Target to $20
Jefferies analyst Chris Howerton downgrades IVERIC bio (NASDAQ:ISEE) from Buy to Hold and lowers the price target from $30 to $20.
HC Wainwright & Co. Maintains Buy on IVERIC bio, Raises Price Target to $35
HC Wainwright & Co. analyst Matthew Caufield maintains IVERIC bio (NASDAQ:ISEE) with a Buy and raises the price target from $26 to $35.